AIDS Healthcare Foundation (AHF) reported on Wednesday that the US will have 3m vaccine doses per day available by April in the fight against the COVID-19 variants.
In conjunction, the company's Ryan White HIV Clinics will offer its sites to administer the COVID-19 vaccines.
On Tuesday, AstraZeneca, Johnson & Johnson, Moderna, Novavax and Pfizer have reportedly testified at the US House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations. Each company presented the scaled-up production numbers for the vaccines that have been approved by the US Food and Drug Administration (FDA).
AHF is the largest global AIDS organization and currently provides medical care and/or services to over 1.5m people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region as well as Eastern Europe.
Krystal Biotech receives FDA approval for updated VYJUVEK label
Renalytix signs collaboration agreement with Tempus AI to expand KidneyIntelX.dkd access
Biophytis secures Brazilian funding and partnerships for obesity Phase 2 trial
Zhimeng Biopharma's investigational drug gains Phase 2 epilepsy clinical trial approval in China
Sanofi's SAR402663 granted FDA fast track designation for wet AMD
Implantica produces 10,000 RefluxStop units ahead of planned US launch
Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA